Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol dosing regimens in adults with persistent asthma
2010-018481-22Phase 2Completed
- Sponsor
- Novartis
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of indacaterol in persistent asthma and asthma (4 arms), sponsored by Novartis. Primary endpoint: Change from baseline in trough FEV1. Started Feb 2010; status: completed.
02
Drugs
indacaterol
03
Conditions
persistent asthmaasthma
Beyond the preview
Go deeper on 2010-018481-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018481-22.